Among a number of chemokines implicated in atherosclerosis, MCP-1 (i.e., CCL2) is the key chemokine responsible for accumulation of inflammatory cells in atherosclerotic lesions after interaction with its receptor CCR2. Here, CCR2 is linked to atherosclerosis.